During the COVID-19 pandemic, research on" cytokine storms" has been reinvigorated in
the field of infectious disease, but it also has particular relevance to cancer research …

The pandemic caused by the novel coronavirus SARS-CoV-2 has placed an unprecedented
burden on healthcare systems around the world. In patients who experience severe disease …

Thehypoxia and profound inflammatory response associated with the pneumonitisobserved
with the SARS-CoV-2 virus responsible for the recent COVID-19 pandemic has …

The Covid-19 pandemic has spread rapidly across the globe, resulting in more than 3
million deaths worldwide. The symptoms of Covid-19 are usually mild and non-specific …

Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in
Patients with COVID-19 | Cancer Discovery | American Association for Cancer Research Skip …

The ongoing pandemic caused by the novel coronavirus SARS-CoV-2 has disrupted the
global economy and strained healthcare systems to their limits. After the virus first emerged …

Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

Patients with cancer, in particular patients with hematologic malignancies, are at increased
risk for critical illness upon COVID-19. We here assessed antibody as well as CD4+ and …

Abstract Interleukin-6 (IL-6) is a multi-tasking cytokine that represents high activity in patients
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cancer. High …

Coronavirus disease 2019 (COVID-19) has swept the world, unlike any other pandemic in
the last 50 years. Our understanding of the disease has evolved rapidly since the outbreak; …